Research News

First cancer patient has new metabolic imaging technique in UK trial

BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2044 (Published 11 April 2016) Cite this as: BMJ 2016;353:i2044
  1. Susan Mayor
  1. London

A patient with cancer has become the first in Europe to undergo scanning with a new metabolic imaging technique, in a UK trial designed to assess whether it can rapidly detect a drug treatment’s effectiveness at killing cancer cells.

The imaging technique uses hyperpolarised pyruvate, a breakdown product of glucose that is labelled with non-radioactive carbon-13 ([1-13C] pyruvate), to characterise alterations in tumour metabolism non-invasively. …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe